Alternative Splicing of Secretin Receptor (SCTR) and Its Low Expression Drive the Occurrence of Pancreatic Ductal Adenocarcinoma
This study provides novel insights into identifying potential therapeutic targets for pancreatic cancer, highlighting that SCTR may serve as a promising prognostic and diagnostic biomarker, with its low expression significantly associated with poor clinical outcomes in PDAC.
Authors
- Feng Gao (ORCID: https://orcid.org/0000-0002-1425-1623)
- Ling Wang (ORCID: https://orcid.org/0000-0002-7225-2878)
- Qicai Liu (ORCID: https://orcid.org/0000-0003-1766-9395)
- Yanqi Ke
Institutions
- Fujian Medical University (CN)
- First Affiliated Hospital of Fujian Medical University (CN)
Publication Details
- Journal
- Pancreas
- Published
- 2025-09-18
- DOI
- https://doi.org/10.1097/mpa.0000000000002569
- Primary Topic
- Cell Adhesion Molecules Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00